Oppenheimer Reiterates Perform on Medtronic, Maintains $89 Price Target
Portfolio Pulse from richadhand@benzinga.com
Oppenheimer analyst Steven Lichtman has reiterated a 'Perform' rating on Medtronic (NYSE:MDT) and maintained a price target of $89.
August 23, 2023 | 12:43 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Oppenheimer analyst has reiterated a 'Perform' rating on Medtronic and maintained a price target of $89.
The news is directly about Medtronic and its rating by Oppenheimer. The 'Perform' rating suggests that the analyst expects the stock to perform in line with the market, which is a neutral outlook. The maintained price target indicates that the analyst's valuation of the company has not changed.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100